Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Sensitivity and Specificity of a Multi-Omic Precision Diagnostic for Acute Stroke Evaluation (VALISS)

NCT02753257 is registered in ClinicalTrials.gov with Valtari Bio as lead sponsor.

NCT NCT02753257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02753257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Sensitivity and Specificity of a Multi-Omic Precision Diagnostic for Acute Stroke Evaluation (VALISS)
Lead sponsor
Valtari Bio
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2016
Completion date
December 31, 2019
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stroke